Changes in the Composition of the Human Fecal Microbiome After Bacteriotherapy for Recurrent Clostridium difficile-associated Diarrhea
The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Abstract
CDAD is the major known cause of antibiotic-induced diarrhea and colitis, and the disease is thought to result from persistent disruption of commensal gut microbiota.Bacteriotherapy by way of fecal transplantation can be used to treat recurrent CDAD and is thought to re-establish the normal colonic microflora.However, limitations of conventional microbiologic techniques have until recently precluded testing of this idea.In this study we used T-RFLP and 16S rRNA gene sequencing approaches to characterize the bacterial composition of the colonic microflora in a patient suffering from recurrent CDAD, before and after treatment by fecal transplantation from a healthy donor.While the patient's residual colonic microbiota, prior to therapy, was deficient in members of the bacterial divisions-Firmicutes and Bacteriodetes, transplantation had a dramatic impact on the composition of the patient's gut microbiota.By 14 days post transplantation, the fecal bacterial composition of the recipient was highly similar to the donor and was dominated by Bacteroides spp.strains and an uncharacterized butyrate producing bacterium.The change in bacterial composition was accompanied by resolution of the patient's symptoms.The striking similarity of the recipient's and donor's intestinal microbiota following bacteriotherapy suggests that the donor's bacteria quickly occupied their requisite niches, resulting in restoration of both the structure and function of the microbial communities present.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Multiple studies have demonstrated remarkable effectiveness of FMT in cases of recurrent and refractory CDI, which may be attributed to sustained restoration of the normal microbiota after FMT.22,23”
From Fecal microbiota transplantation: Review and update (2019) · cites this paper as [22]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Indeed, studies have demonstrated that patients suffering from recurrent CDI are deficient in phyla of bacteria normally dominant in the colon6,45 (Figure 1).”
From Update on Fecal Microbiota Transplantation 2015: Indications, Methodologies, Mechanisms, and Outlook (2015) · cites this paper as [6]
In the citing paper
“Moreover, the restoration of more typical microbial communities, which come to resemble those of the donor post-transplant, persists in a durable fashion after FMT.6, 7”
From Update on Fecal Microbiota Transplantation 2015: Indications, Methodologies, Mechanisms, and Outlook (2015) · cites this paper as [6]
In the citing paper
“FMT appears to result in durable engraftment of new species from donor as well as augmentation of species present at only very low levels prior to FMT6.”
From Update on Fecal Microbiota Transplantation 2015: Indications, Methodologies, Mechanisms, and Outlook (2015) · cites this paper as [6]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
An obesity-associated gut microbiome with increased capacity for energy harvest
Turnbaugh, P. J., Ley, R. E., Mahowald, M. A., Magrini, V., Mardis, E. R., & Gordon, J. I. (2006) · Nature · doi:10.1038/nature05414 · Cited by 12,444
Muyzer, G., de Waal, E. C., & Uitterlinden, A. G. (1993) · Applied and Environmental Microbiology · doi:10.1128/aem.59.3.695-700.1993 · Cited by 11,429
Human gut microbes associated with obesity
Ley, R. E., Turnbaugh, P. J., Klein, S., & Gordon, J. I. (2006) · Nature · doi:10.1038/4441022a · Cited by 8,785 · cited 1×
“Many Firmicutes produce butyrate and are postulated to be involved in obesity in humans and murine models.(32,33) Short chain length fatty acids (SCFAs), especially butyrate, have also been shown to play a critical role in maintaining integrity of the colonic epithelium and regulation of the mucosal immune responses.”
BackgroundDiversity of the Human Intestinal Microbial Flora
Eckburg, P. B., Bik, E. M., Bernstein, C. N., Purdom, E., Dethlefsen, L., Sargent, M., Gill, S. R., Nelson, K. E., & Relman, D. A. (2005) · Science · doi:10.1126/science.1110591 · Cited by 7,913
Ecological and Evolutionary Forces Shaping Microbial Diversity in the Human Intestine
Ley, R. E., Peterson, D. A., & Gordon, J. I. (2006) · Cell · doi:10.1016/j.cell.2006.02.017 · Cited by 3,358 · cited 1×
“These bacteria are well-known dominant members of human fecal microbiota,(16) and these phyla are thought to play major ecologic roles in establishment and maintenance of gut homeostasis.(30) A lack of Bacteroides sp.”
BackgroundDevelopment of the Human Infant Intestinal Microbiota
Palmer, C., Bik, E. M., DiGiulio, D. B., Relman, D. A., & Brown, P. O. (2007) · PLoS Biology · doi:10.1371/journal.pbio.0050177 · Cited by 2,877
Edwards, U., Rogall, T., Blöcker, H., Emde, M., & Böttger, E. C. (1989) · Nucleic Acids Research · doi:10.1093/nar/17.19.7843 · Cited by 2,724 · cited 1×
“primers Bact-8F (5’-AGAGTTTGATCCTGGCTCAG-3’) [25] 5′ end-labeled with 6-”
Dethlefsen, L., Huse, S., Sogin, M. L., & Relman, D. A. (2008) · PLoS Biology · doi:10.1371/journal.pbio.0060280 · Cited by 2,361
Clostridium difficile— More Difficult Than Ever
Kelly, C. P., & LaMont, J. T. (2008) · New England Journal of Medicine · doi:10.1056/nejmra0707500 · Cited by 1,313 · cited 4×
“Unfortunately, the same problem is encountered by others treating this disease.(1) In the studies reported here, we used a molecular approach to gain a better understanding of the bacterial composition of the GI tract in a CDAD patient.”
BackgroundInfluentialDecreased Diversity of the Fecal Microbiome in Recurrent Clostridium difficile–Associated Diarrhea
Chang, J. Y., Antonopoulos, D. A., Kalra, A., Tonelli, A., Khalife, W. T., Schmidt, T. M., & Young, V. B. (2008) · The Journal of Infectious Diseases · doi:10.1086/525047 · Cited by 1,010 · cited 2×
“However, the composition and species richness of intestinal tract microbiota in individuals with CDAD and recurrent CDAD were found to be markedly different from controls.(14) The reestablishment of the normal composition of the intestinal flora has long been hypothesized to be a curative approach for the recurrent CD…”
Background
Cited by
Items 101–200 of 645
Probiotic Approach to Pathogen Control in Premise Plumbing Systems? A Review
Wang, H., Edwards, M. A., Falkinham, J. O., & Pruden, A. (2013) · Environmental Science & Technology · doi:10.1021/es402455r · Cited by 175
Antibiotics and the resistant microbiome
Sommer, M. O., & Dantas, G. (2011) · Current Opinion in Microbiology · doi:10.1016/j.mib.2011.07.005 · Cited by 174
“Almost every surface of the human body after birth is colonized by a rich and diverse community of commensal microbes [4-6], and this microbiota has substantial and continuous effects on human health and physiological development, including dietary and nutritional processing, prevention of pathogen invasion, and immun…”
BackgroundFuentes, S., van Nood, E., Tims, S., Heikamp-de Jong, I., ter Braak, C. J. F., Keller, J. J., Zoetendal, E. G., & de Vos, W. M. (2014) · The ISME Journal · doi:10.1038/ismej.2014.13 · Cited by 175
“Although it is generally believed that the efficacy of FMT can be explained by restoration of healthy gut microbiota, there are still few studies addressing the microbial composition and dynamics triggered by FMT (Khoruts et al., 2010; Manichanh et al., 2010; Rea et al., 2011; Petrof et al., 2013).”
BackgroundMethodThe role of the gut microbiome in chronic liver disease: the clinical evidence revised
Schwenger, K. J., Clermont-Dejean, N., & Allard, J. P. (2019) · JHEP Reports · doi:10.1016/j.jhepr.2019.04.004 · Cited by 171
Microbiota changes and intestinal microbiota transplantation in liver diseases and cirrhosis
Bajaj, J. S., & Khoruts, A. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2020.01.017 · Cited by 167
Self-citationSong, Y., Garg, S., Girotra, M., Maddox, C., von Rosenvinge, E. C., Dutta, A., Dutta, S., & Fricke, W. F. (2013) · PLoS ONE · doi:10.1371/journal.pone.0081330 · Cited by 172
“Fecal microbiota transplantation (FMT), which aims to restore a normal, functional intestinal microbiota from a healthy donor in the RCDI patient, has recently received increasing attention in clinical and research communities [24–27] and has also become a popular subject of discussion in other media.”
BackgroundBriliūtė, J., Urbanowicz, P. A., Luis, A. S., Baslé, A., Paterson, N., Rebello, O., Hendel, J., Ndeh, D. A., Lowe, E. C., Martens, E. C., et al. (2019) · Nature Microbiology · doi:10.1038/s41564-019-0466-x · Cited by 173
Microbiota-Immune Interaction in the Pathogenesis of Gut-Derived Infection
Wang, C., Li, Q., & Ren, J. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01873 · Cited by 166
“Many studies have indicated that the composition and diversity of the fecal microbiota in patients with CDI are pronouncedly altered, and the dysbiosis is associated with the infection and its resistance to antibiotic therapy (132, 133).”
BackgroundThe role of the skin microbiome in atopic dermatitis
Nakatsuji, T., & Gallo, R. L. (2019) · Annals of Allergy, Asthma & Immunology · doi:10.1016/j.anai.2018.12.003 · Cited by 163
Gut integrity in critical illness
Otani, S., & Coopersmith, C. M. (2019) · Journal of Intensive Care · doi:10.1186/s40560-019-0372-6 · Cited by 164
Correlation between human gut microbiome and diseases
Madhogaria, B., Bhowmik, P., & Kundu, A. (2022) · Infectious Medicine · doi:10.1016/j.imj.2022.08.004 · Cited by 198
Induced Systemic Resistance and the Rhizosphere Microbiome
Bakker, P. A. H. M., Doornbos, R. F., Zamioudis, C., Berendsen, R. L., & Pieterse, C. M. J. (2013) · The Plant Pathology Journal · doi:10.5423/ppj.si.07.2012.0111 · Cited by 163
Antibiotic administration alters the community structure of the gastrointestinal microbiota
Robinson, C. J., & Young, V. B. (2010) · Gut Microbes · doi:10.4161/gmic.1.4.12614 · Cited by 161
The intestinal microbiota in health and disease
Young, V. B. (2012) · Current Opinion in Gastroenterology · doi:10.1097/mog.0b013e32834d61e9 · Cited by 162
How the microbiota shapes rheumatic diseases
Van de Wiele, T., Van Praet, J. T., Marzorati, M., Drennan, M. B., & Elewaut, D. (2016) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2016.85 · Cited by 159
Ling, Z., Liu, X., Jia, X., Cheng, Y., Luo, Y., Yuan, L., Wang, Y., Zhao, C., Guo, S., Li, L., et al. (2014) · Scientific Reports · doi:10.1038/srep07485 · Cited by 158
Weingarden, A. R., Dosa, P. I., DeWinter, E., Steer, C. J., Shaughnessy, M. K., Johnson, J. R., Khoruts, A., & Sadowsky, M. J. (2016) · PLOS ONE · doi:10.1371/journal.pone.0147210 · Cited by 153
Self-citationFaecal microbiota transplantation for Clostridioides difficile: mechanisms and pharmacology
Khoruts, A., Staley, C., & Sadowsky, M. J. (2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-020-0350-4 · Cited by 155
Self-citationMicrobiome and Breast Cancer: New Role for an Ancient Population
Eslami-S, Z., Majidzadeh-A, K., Halvaei, S., Babapirali, F., & Esmaeili, R. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00120 · Cited by 153
Duplessis, C. A., Bavaro, M. F., Simons, M. P., Marguet, C. G., Santomauro, M., Auge, B. K., Collard, D. A., Fierer, J., & L’Esperance, J. O. (2012) · Urology · doi:10.1016/j.urology.2011.09.057 · Cited by 161
Reduced Diversity and Imbalance of Fecal Microbiota in Patients with Ulcerative Colitis
Nemoto, H., Kataoka, K., Ishikawa, H., Ikata, K., Arimochi, H., Iwasaki, T., Ohnishi, Y., Kuwahara, T., & Yasutomo, K. (2012) · Digestive Diseases and Sciences · doi:10.1007/s10620-012-2236-y · Cited by 177
“However, bacteriotherapy with fecal suspension prepared from a normal donor altered the microbioa of the patient to resemble that of the donor, with resolution of the symptoms [60].”
Sood, A., Mahajan, R., Singh, A., Midha, V., Mehta, V., Narang, V., Singh, T., & Singh Pannu, A. (2019) · Journal of Crohn's and Colitis · doi:10.1093/ecco-jcc/jjz060 · Cited by 149
Stewardson, A. J., Gaïa, N., François, P., Malhotra-Kumar, S., Delémont, C., de Tejada, B. M., Schrenzel, J., Harbarth, S., & Lazarević, V. (2014) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2014.11.016 · Cited by 161
“perturbation of intestinal microbiota has been associated with the development of Clostridium difficile–associated diarrhoea and colonization by vancomycin-resistant bacteria [26,27].”
BackgroundOlle, B. (2013) · Nature Biotechnology · doi:10.1038/nbt.2548 · Cited by 160
Fecal Microbiota Transplantation
Borody, T. J., & Campbell, J. (2012) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2012.08.008 · Cited by 115
Rousseau, C., Levenez, F., Fouqueray, C., Doré, J., Collignon, A., & Lepage, P. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.01507-10 · Cited by 138
“Recent studies suggest that restoration of the microbiota by the use of bacteriotherapy (probiotic use and fecal transplantation) is accompanied by resolution of patients’ symptoms (13, 17).”
BackgroundClostridium Difficile Infection
Lübbert, C., John, E., & von Müller, L. (2014) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.2014.0723 · Cited by 178
The intestinal microbiota and susceptibility to infection in immunocompromised patients
Taur, Y., & Pamer, E. G. (2013) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0b013e3283630dd3 · Cited by 139
“Fecal microbiota transplantation (FMT) has been gaining notoriety as an effective way to cure patients with recurrent CDI, often succeeding in instances wherein other treatments have failed [58].”
BackgroundRubin, T. A., Gessert, C. E., Aas, J., & Bakken, J. (2012) · Anaerobe · doi:10.1016/j.anaerobe.2012.11.004 · Cited by 142
Sha, S., Liang, J., Chen, M., Xu, B., Liang, C., Wei, N., & Wu, K. (2014) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.12699 · Cited by 134
“et al.(60), who also found the change in bacterial composition was accompanied by resolution of the patient’s symptoms.”
Wang, Z.-K. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i40.14805 · Cited by 133
The Microbiome as a Component of the Tumor Microenvironment
Kovàcs, T., Mikó, E., Ujlaki, G., Sári, Z., & Bai, P. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-35727-6_10 · Cited by 140
Microbial ecosystems therapeutics: a new paradigm in medicine?
Petrof, E. O., Claud, E. C., Gloor, G. B., & Allen-Vercoe, E. (2013) · Beneficial Microbes · doi:10.3920/bm2012.0039 · Cited by 123
“In an attempt to investigate this issue, one small study used culture-independent techniques in a patient with recurrent CDI who received faecal microbial reconstitution (Khoruts et al., 2010).”
BackgroundInfluentialNew insights into therapeutic strategies for gut microbiota modulation in inflammatory diseases
Vieira, A. T., Fukumori, C., & Ferreira, C. M. (2016) · Clinical & Translational Immunology · doi:10.1038/cti.2016.38 · Cited by 121
Fang, H., Fu, L., & Wang, J. (2018) · BioMed Research International · doi:10.1155/2018/8941340 · Cited by 123
Whiteson, K. L., Bailey, B., Bergkessel, M., Conrad, D., Delhaes, L., Felts, B., Harris, J. K., Hunter, R., Lim, Y. W., Maughan, H., et al. (2014) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201312-2129pp · Cited by 123
“Overall, although there are limitations associated with sputum samples, the fact that they can be obtained by noninvasive means, and that they show patterns of diversity similar to lower and upper airways (8, 15, 16, 34), suggest it is sensible to obtain as much information from sputum samples as possible.”
Insights into Gut Dysbiosis: Inflammatory Diseases, Obesity, and Restoration Approaches
Acevedo-Román, A., Pagán-Zayas, N., Velázquez-Rivera, L. I., Torres-Ventura, A. C., & Godoy‐Vitorino, F. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25179715 · Cited by 142
“This first report shows how natural fecal microbial communities positively impact the balance of the gut microbiome [107].”
BackgroundIntestinal microbiota and its effects on the immune system: The immune system and the microbiota
Rescigno, M. (2014) · Cellular Microbiology · doi:10.1111/cmi.12301 · Cited by 121
“One important function is the maturation of the immune system and protection against some infectious agents (Khoruts et al., 2010; Reid et al., 2011; Swiatczak et al., 2011; Hooper et al., 2012).”
BackgroundPostigo, R., & Kim, J. H. (2012) · Infection · doi:10.1007/s15010-012-0307-9 · Cited by 124
Molecular Alteration Analysis of Human Gut Microbial Composition in Graves' disease Patients
Ishaq, H. M., Mohammad, I. S., Shahzad, M., Ma, C., Raza, M. A., Wu, X., Guo, H., Shi, P., & Xu, J. (2018) · International Journal of Biological Sciences · doi:10.7150/ijbs.24151 · Cited by 130
“smoking, obesity, colitis, type II diabetes, Hashimoto’s thyroiditis and asthma [4-7].”
BackgroundThe microbiota and its metabolites in colonic mucosal health and cancer risk
Vipperla, K., & O'Keefe, S. J. (2012) · Nutrition in Clinical Practice · doi:10.1177/0884533612452012 · Cited by 116
“Fecal bacteriotherapy, transplantation of normal bacterial flora from stool obtained from a healthy donor, has been shown to be remarkably successful in the treatment of chronic recurrent CDI, restoring the numbers of Firmicutes and Bacteroidetes.83 at Umea University Library on August 19, 2014ncp.sagepub.comDownloade…”
BackgroundGut Microbe Analysis Between Hyperthyroid and Healthy Individuals
Zhou, L., Li, X., Ahmed, A., Wu, D., Liu, L., Qiu, J., Yan, Y., Jin, M., & Xin, Y. (2014) · Current Microbiology · doi:10.1007/s00284-014-0640-6 · Cited by 127
“Unfortunately, abnormalities in the composition of gut microbiota have been implicated in many disease states, including malnutrition, inflammatory bowel disease, Crohn’s disease, and colitis colon, as well as metabolic diseases including obesity and type II diabetes [6, 10].”
Ishaq, H. M., Mohammad, I. S., Guo, H., Shahzad, M., Hou, Y. J., Ma, C., Naseem, Z., Wu, X., Shi, P., & Xu, J. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.08.101 · Cited by 128
Clostridium difficile infection: a review of current and emerging therapies
Ofosu, A. (2016) · Annals of Gastroenterology · doi:10.20524/aog.2016.0006 · Cited by 127
Cross-kingdom similarities in microbiome functions
Mendes, R., & Raaijmakers, J. M. (2015) · The ISME Journal · doi:10.1038/ismej.2015.7 · Cited by 111
Neemann, K., Eichele, D. D., Smith, P. W., Bociek, R., Akhtari, M., & Freifeld, A. (2012) · Transplant Infectious Disease · doi:10.1111/tid.12017 · Cited by 107
Staley, C., Kelly, C. R., Brandt, L. J., Khoruts, A., & Sadowsky, M. J. (2016) · mBio · doi:10.1128/mbio.01965-16 · Cited by 105
“Since the proliferation of C. difficile typically occurs following a reduction in diversity of the intestinal microbial community, res-RESEARCH toration of this diversity provides a promising avenue to treat rCDI (13, 14).”
Self-citationShankar, V., Hamilton, M. J., Khoruts, A., Kilburn, A., Unno, T., Paliy, O., & Sadowsky, M. J. (2014) · Microbiome · doi:10.1186/2049-2618-2-13 · Cited by 106
“Recent studies from our group showed that the eradication of the disease symptoms is accompanied by a dramatic shift in the microbial community as examined by TRFLP and gene sequencing analyses [8,9].”
Self-citationFuture directions in inflammatory bowel disease management
D’Haens, G., Sartor, R. B., Silverberg, M. S., Petersson, J. H., & Rutgeerts, P. J. (2014) · Journal of Crohn s and Colitis · doi:10.1016/j.crohns.2014.02.025 · Cited by 121
Community Health Care: Therapeutic Opportunities in the Human Microbiome
Sonnenburg, J. L., & Fischbach, M. A. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3001626 · Cited by 102
Landy, J., Al-Hassi, H. O., McLaughlin, S. D., Walker, A. W., Ciclitira, P. J., Nicholls, R. J., Clark, S. K., & Hart, A. L. (2011) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2011.04737.x · Cited by 100
“Following faecal transplantation, there was a rapid change in the patient’s microbiota to a composition that was highly similar to that of the healthy donor for at least 4 weeks (the duration of follow-up stool analysis).(28) Grehan et al.”
MethodBrown, J. R.-M., Flemer, B., Joyce, S. A., Zulquernain, A., Sheehan, D., Shanahan, F., & O’Toole, P. W. (2018) · BMC Gastroenterology · doi:10.1186/s12876-018-0860-5 · Cited by 99
Infection Control in the Multidrug-Resistant Era: Tending the Human Microbiome
Tosh, P. K., & McDonald, L. C. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir899 · Cited by 111
“To date, the most successful method for restoring the mammalian intestinal flora has been through fecal microbiota transplantation (FMT), for example, either from a donor mouse placed in the same cage, as in the study by Antonopoulos et al, or the growing number of successful human FMTs performed to treat recurrent C.…”
Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection
Brandt, L. J., & Reddy, S. S. (2011) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0b013e318222e603 · Cited by 98
Aroniadis, O. C., Brandt, L. J., Greenberg, A., Borody, T., Kelly, C. R., Mellow, M., Surawicz, C., Cagle, L., Neshatian, L., Stollman, N., et al. (2016) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0000000000000374 · Cited by 96
Ihekweazu, F. D., Fofanova, T. Y., Queliza, K., Nagy-Szakal, D., Stewart, C. J., Engevik, M. A., Hulten, K. G., Tatevian, N., Graham, D. Y., Versalovic, J., et al. (2019) · Gut Microbes · doi:10.1080/19490976.2018.1560753 · Cited by 100
Raufaste-Cazavieille, V., Santiago, R., & Droit, A. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.962743 · Cited by 110
“Considering the high plasticity of the microbiome constitution, longitudinal analysis of the flora should be preferred (Turnbaugh et al., 2009; Khoruts et al., 2010; Spencer et al., 2011; Kong et al., 2012).”
BackgroundComputational systems biology and in silico modeling of the human microbiome
Borenstein, E. (2012) · Briefings in Bioinformatics · doi:10.1093/bib/bbs022 · Cited by 98
“Microbiome transplantation was recently shown, for example, to successfully resolve recurrent Clostridium difficile infection, re-establishing a normal and stable microbiota [95–97].”
BackgroundFrenemies: Signaling and Nutritional Integration in Pathogen-Microbiota-Host Interactions
Cameron, E. A., & Sperandio, V. (2015) · Cell Host & Microbe · doi:10.1016/j.chom.2015.08.007 · Cited by 97
“This shift in microbiota composition corresponds with a successful recovery in CDI patients receiving microbiota transplant (Khoruts et al., 2010), demonstrating how the community can be manipulated to successfully treat disease.”
BackgroundEmergent Biosynthetic Capacity in Simple Microbial Communities
Chiu, H.-C., Levy, R., & Borenstein, E. (2014) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1003695 · Cited by 107
“Such transplantation efforts currently utilize complete microbiome transfers from healthy donors or simple synthetic microbiomes constructed from a small collection of carefully handpicked strains [19,21,22].”
BackgroundThe microbiota and helminths: sharing the same niche in the human host
GLENDINNING, L., NAUSCH, N., FREE, A., TAYLOR, D. W., & MUTAPI, F. (2014) · Parasitology · doi:10.1017/s0031182014000699 · Cited by 95
“Their life history and clinical management can affect the composition and structure of the gut microbiome (Khoruts et al. 2010; Dethlefsen and Relman, 2011).”
Hensley‐McBain, T., Zevin, A. S., Manuzak, J. A., Smith, E. A., Gile, J., Miller, C. J., Agricola, B. A., Katze, M. G., Reeves, R. K., Kraft, C. S., et al. (2016) · Journal of Virology · doi:10.1128/jvi.00099-16 · Cited by 102
“However, given the extensive selection for a diverse community of anaerobic Gram-negative bacteria induced by antibiotics, this is unlikely, and furthermore, previous studies have demonstrated that the recipient microbiome resembles the donor microbiome post-FMT (42).”
ResultRecurrent Clostridium difficile infection: From colonization to cure
Shields, K., Araujo-Castillo, R. V., Theethira, T. G., Alonso, C. D., & Kelly, C. P. (2015) · Anaerobe · doi:10.1016/j.anaerobe.2015.04.012 · Cited by 93
Crosstalk between gut microbiota and host immune system and its response to traumatic injury
Ullah, H., Arbab, S., Tian, Y., Chen, Y., Liu, C., Li, Q., & Li, K. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1413485 · Cited by 112
The human microbiome in hematopoiesis and hematologic disorders
Manzo, V. E., & Bhatt, A. S. (2015) · Blood · doi:10.1182/blood-2015-04-574392 · Cited by 92
“This technique has been used to successfully treat recurrent Clostridium difficile–associated disease.(76) FMT results in a change in bacterial composition that is accompanied by resolution of patient symptoms.”
BackgroundMethodFecal microbiota transplantation: facts and controversies
van Nood, E., Speelman, P., Nieuwdorp, M., & Keller, J. (2014) · Current Opinion in Gastroenterology · doi:10.1097/mog.0000000000000024 · Cited by 92
Metabolic independence drives gut microbial colonization and resilience in health and disease
Watson, A. R., Füssel, J., Veseli, I., DeLongchamp, J. Z., Silva, M., Trigodet, F., Lolans, K., Shaiber, A., Fogarty, E., Runde, J. M., et al. (2023) · Genome Biology · doi:10.1186/s13059-023-02924-x · Cited by 92
Advances in Fecal Microbiota Transplantation for Gut Dysbiosis‐Related Diseases
Hou, S., Yu, J., Li, Y., Zhao, D., & Zhang, Z. (2025) · Advanced Science · doi:10.1002/advs.202413197 · Cited by 117
Marchesi, J. R. (2011) · Environmental Microbiology · doi:10.1111/j.1462-2920.2011.02574.x · Cited by 91
“…2008b; Sobhani et al., 2011), irritable bowel syndrome (Kassinen et al., 2007; O’Mahony et al., 2009) and Clostridium difficileassociated diarrhoea (Khoruts et al., 2010) and more recently in ex-intestinal diseases such as cardiovascular disease (Wang et al., 2011), obesity {Turnbaugh, 2008…”
BackgroundTreatment of refractory and recurrent Clostridium difficile infection
Surawicz, C. M., & Alexander, J. (2011) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2011.59 · Cited by 93
Standardized Preparation for Fecal Microbiota Transplantation in Pigs
Hu, J. P., Chen, L., Tang, Y., Xie, C., Xu, B., Shi, M. Y., Zheng, W., Zhou, S., Wang, X., Liu, L., et al. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.01328 · Cited by 100
“Growing evidences have revealed the similarity between intestinal microbiota of recipients and donors as well as the normalization of gut microbial compositions and functions in recipients after FMT therapy in human (Khoruts et al., 2010; Li et al., 2016).”
BackgroundOur microbial selves: what ecology can teach us
Gonzalez, A., Clemente, J. C., Shade, A. L., Metcalf, J. L., Song, S., Prithiviraj, B., Palmer, B. E., & Knight, R. D. (2011) · EMBO Reports · doi:10.1038/embor.2011.137 · Cited by 109
“Questions about the ability of a species to invade are important given the interest in stool transplantation, which seems to be an effective treatment for persistent, antibiotic-resistant Clostridium difficile infections”
BackgroundThe Human Microbiome and the Missing Heritability Problem
Sandoval-Motta, S., Aldana, M., Martínez-Romero, E., & Frank, A. (2017) · Frontiers in Genetics · doi:10.3389/fgene.2017.00080 · Cited by 90
Fecal bacteriotherapy for ulcerative colitis: Patients are ready, are we?
Kahn, S. A., Gorawara‐Bhat, R., & Rubin, D. T. (2011) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21775 · Cited by 96
“Other groups have shown that FMT alters the host microbiota in a sustained manner that correlates with clearance of the infection.(22,23) These studies have significant implications for IBD patients who similarly may benefit from FMT.”
BackgroundWick, E. C., & Sears, C. L. (2010) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0b013e32833da1eb · Cited by 96
Microbiome mediation of infections in the cancer setting
Taur, Y., & Pamer, E. G. (2016) · Genome Medicine · doi:10.1186/s13073-016-0306-z · Cited by 89
“difficile infection who were cured using fecal microbiota transplantation (FMT), examination of the microbiota before and after FMT revealed that the most obvious microbial change was significant colonization with Bacteroidetes, where it had been previously completely lacking [39, 40].”
BackgroundEvolutionary analyses of non-genealogical bonds produced by introgressive descent
Bapteste, E. P., Lopez, P., Bouchard, F., Baquero, F., McInerney, J. O., & Burian, R. M. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1206541109 · Cited by 105
Probiotic Use in Horses – What is the Evidence for Their Clinical Efficacy?
Schoster, A., Weese, J. S., & Guardabassi, L. (2014) · Journal of Veterinary Internal Medicine · doi:10.1111/jvim.12451 · Cited by 117
Therapeutic transplantation of the distal gut microbiota
Khoruts, A., & Sadowsky, M. J. (2010) · Mucosal Immunology · doi:10.1038/mi.2010.79 · Cited by 97
Self-citationKao, D., Hotte, N., Gillevet, P., & Madsen, K. (2014) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0000000000000131 · Cited by 87
Probiotics and irritable bowel syndrome
Dai, C. (2013) · World Journal of Gastroenterology · doi:10.3748/wjg.v19.i36.5973 · Cited by 85
Stewart, H. L., Southwood, L. L., Indugu, N., Vecchiarelli, B., Engiles, J. B., & Pitta, D. (2018) · Equine Veterinary Journal · doi:10.1111/evj.13010 · Cited by 91
Patient Perceptions of Fecal Microbiota Transplantation for Ulcerative Colitis
Kahn, S. A., Vachon, A., Rodriquez, D., Goeppinger, S. R., Surma, B., Marks, J., & Rubin, D. T. (2013) · Inflammatory Bowel Diseases · doi:10.1097/mib.0b013e318281f520 · Cited by 85
Effects of transport, fasting and anaesthesia on the faecal microbiota of healthy adult horses
Schoster, A., Mosing, M., Jalali, M., Staempfli, H. R., & Weese, J. S. (2015) · Equine Veterinary Journal · doi:10.1111/evj.12479 · Cited by 97
From Animalcules to an Ecosystem: Application of Ecological Concepts to the Human Microbiome
Fierer, N., Ferrenberg, S., Flores, G. E., González, A., Kueneman, J., Legg, T., Lynch, R. C., McDonald, D., Mihaljevic, J. R., O'Neill, S. P., et al. (2012) · Annual Review of Ecology, Evolution, and Systematics · doi:10.1146/annurev-ecolsys-110411-160307 · Cited by 84
Lee, Y. J., Arguello, E. S., Jenq, R. R., Littmann, E., Kim, G. J., Miller, L. C., Ling, L., Figueroa, C., Robilotti, E., Perales, M.-A., et al. (2017) · The Journal of Infectious Diseases · doi:10.1093/infdis/jix011 · Cited by 84
Colonization Resistance of the Gut Microbiota against Clostridium difficile
Pérez-Cobas, A., Moya, A., Gosalbes, M., & Latorre, A. (2015) · Antibiotics · doi:10.3390/antibiotics4030337 · Cited by 83
“of patients [96,105,114–119].”
A Canadian Working Group report on fecal microbial therapy: microbial ecosystems therapeutics
Allen-Vercoe, E., Reid, G., Viner, N., Gloor, G. B., Hota, S., Kim, P., Lee, C., O’Doherty, K. C., Vanner, S. J., Weese, J. S., et al. (2012) · Canadian Journal of Gastroenterology · doi:10.1155/2012/213828 · Cited by 81
“Recurrent CDI is believed to result from the inability of the intestinal microbiota to recover and re-establish itself to homeostasis with the host (we henceforth use the term ‘normal’ to mean one that does not cause symptoms and signs of infection), after an initial insult, such as antimicrobial exposure (7-10).”
BackgroundDutta, S., Girotra, M., Garg, S., Dutta, A., von Rosenvinge, E. C., Maddox, C., Song, Y., Bartlett, J. G., Vinayek, R., & Fricke, W. F. (2014) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2013.12.032 · Cited by 84
NIR light-responsive bacteria with live bio-glue coatings for precise colonization in the gut
Cui, M., Sun, T., Li, S., Pan, H., Liu, J., Zhang, X., Li, L., Li, S., Wei, C., Yu, C., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109690 · Cited by 81
de Vos, W. M. (2013) · Microbial Biotechnology · doi:10.1111/1751-7915.12047 · Cited by 80
“This analysis extended previous studies in a single (Khoruts et al., 2010) or limited number of subjects with fresh (Shahinas et al.”
ResultEnteric pathogens through life stages
Kolling, G. L., Wu, M., & Guerrant, R. L. (2012) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2012.00114 · Cited by 98
Treatment of recurrent Clostridium difficile infection: a systematic review
O’Horo, J. C., Jindai, K., Kunzer, B., & Safdar, N. (2014) · Infection · doi:10.1007/s15010-013-0496-x · Cited by 80
Antibiotics and specialized metabolites from the human microbiota
Mousa, W. K., Athar, B., Merwin, N. J., & Magarvey, N. A. (2017) · Natural Product Reports · doi:10.1039/c7np00021a · Cited by 87
Carlucci, C., Petrof, E. O., & Allen-Vercoe, E. (2016) · EBioMedicine · doi:10.1016/j.ebiom.2016.09.029 · Cited by 77
“…and increases in Firmicutes and Bacteroidetes have been widely observed in CDI patients following FMT (Fuentes et al., 2014; Hamilton et al., 2013; Kelly et al., 2016; Khoruts et al., 2010; Seekatz et al., 2014; Shahinas et al., 2012; van Nood et al., 2013; Weingarden et al., 2015) (see Table 1).”
BackgroundHudson, L. E., Anderson, S. E., Corbett, A. H., & Lamb, T. J. (2016) · Clinical Microbiology Reviews · doi:10.1128/cmr.00049-16 · Cited by 88
Newman, K. M., Rank, K. M., Vaughn, B. P., & Khoruts, A. (2017) · Gut Microbes · doi:10.1080/19490976.2017.1279377 · Cited by 75
Self-citationComparison of the Distal Gut Microbiota from People and Animals in Africa
Ellis, R. J., Bruce, K. D., Jenkins, C., Stothard, J. R., Ajarova, L., Mugisha, L., & Viney, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0054783 · Cited by 88
“Clostridium difficile [25] and in inflammatory bowel disease [26–28].”
BackgroundKronman, M. P., Nielson, H. J., Adler, A. L., Giefer, M. J., Wahbeh, G., Singh, N., Zerr, D. M., & Suskind, D. L. (2015) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0000000000000545 · Cited by 76
Friedman‐Moraco, R., Mehta, A. K., Lyon, G. M., & Kraft, C. S. (2014) · American Journal of Transplantation · doi:10.1111/ajt.12577 · Cited by 75
“The restoration of the microbiota to a homeostatic state allows symptomatic CDI to resolve, and the normal predominance of anaerobic bacteria to return (15).”
Background
Metadata
- Authors
- Khoruts, A., Dicksved, J., Jansson, J. K., & Sadowsky, M. J.
- Affiliations
- University of Minnesota (US)
- Swedish University of Agricultural Sciences (SE)
- Lawrence Berkeley National Laboratory (US)
- Corresponding author
- Khoruts, Alexander
- Venue
- Journal of Clinical Gastroenterology
- Published
- 2010-05
- Volume
- 44
- Issue
- 5
- Pages
- 354-360
- ISSN
- 0192-0790 (ISSN-L)
- OpenAlex
- W2095040140
- Cited by
- 649
- References
- 37
- Citations by year
- 2026: 6 · 2025: 15 · 2024: 22 · 2023: 14 · 2022: 13 · 2021: 26 · 2020: 29 · 2019: 41 · 2018: 49 · 2017: 49 · 2016: 53 · 2015: 49 · 2014: 69 · 2013: 88 · 2012: 47
- FWCI
- 44.22
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Clinical Gastroenterology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Clostridium difficile and Clostridium perfringens research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Keywords
- Clostridium difficile-associated diarrhea, fecal microbiota transplantation, gut microbiota composition, colonic microbiota, Firmicutes, Bacteroidetes, Bacteroides, butyrate-producing bacteria, antibiotic-associated diarrhea
- MeSH terms
- Enterocolitis, Pseudomembranous, Feces, Female, Follow-Up Studies, Humans, Middle Aged, Polymorphism, Restriction Fragment Length, RNA, Ribosomal, 16S, Clostridioides difficile, Sequence Analysis, RNA, Metagenome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.